πŸ‡ΊπŸ‡Έ FDA
Patent

US 7732196

Anti-angiogenic methods and compositions

granted A61KA61K38/00A61P

Quick answer

US patent 7732196 (Anti-angiogenic methods and compositions) held by Sangamo Biosciences, Inc. expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P35/00